Vitra Bioscience

Vitra Bioscience was a biotechnology company that specialized in developing high-throughput, multiplexed cell-based assays for the drug discovery and development market. The company's core technology, the CellCard System, allowed researchers to perform multiple cellular assays simultaneously within a single microplate well, significantly increasing throughput and data consistency. By using micro-carriers to uniquely identify different cell populations, the platform enabled complex lead optimization and toxicity screening. Vitra's solutions were designed to bridge the gap between molecular assays and animal models by providing more physiologically relevant data early in the discovery process. The company was acquired by Molecular Devices in 2006 to bolster their cellular analysis and imaging portfolio.